JPL Wealth Management LLC Sells 36,655 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

JPL Wealth Management LLC lowered its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 84.6% in the first quarter, according to its most recent disclosure with the SEC. The firm owned 6,662 shares of the healthcare conglomerate's stock after selling 36,655 shares during the period. UnitedHealth Group accounts for approximately 1.3% of JPL Wealth Management LLC's holdings, making the stock its 25th largest position. JPL Wealth Management LLC's holdings in UnitedHealth Group were worth $3,295,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently made changes to their positions in UNH. Citizens National Bank Trust Department lifted its stake in shares of UnitedHealth Group by 1.0% during the 1st quarter. Citizens National Bank Trust Department now owns 17,886 shares of the healthcare conglomerate's stock worth $9,368,000 after buying an additional 170 shares during the last quarter. Fort Washington Investment Advisors Inc. OH lifted its holdings in UnitedHealth Group by 0.3% during the 1st quarter. Fort Washington Investment Advisors Inc. OH now owns 530,103 shares of the healthcare conglomerate's stock worth $277,641,000 after purchasing an additional 1,465 shares during the last quarter. Sherbrooke Park Advisers LLC acquired a new position in UnitedHealth Group in the 4th quarter valued at $515,000. Full Sail Capital LLC lifted its holdings in shares of UnitedHealth Group by 2.1% during the fourth quarter. Full Sail Capital LLC now owns 1,612 shares of the healthcare conglomerate's stock worth $815,000 after buying an additional 33 shares in the last quarter. Finally, Soros Fund Management LLC bought a new position in UnitedHealth Group during the fourth quarter worth about $39,413,000. 87.86% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of equities research analysts recently issued reports on UNH shares. Hsbc Global Res downgraded UnitedHealth Group from a "hold" rating to a "moderate sell" rating in a research report on Wednesday, May 21st. Baird R W downgraded UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, June 11th. Truist Financial reduced their price objective on shares of UnitedHealth Group from $360.00 to $345.00 and set a "buy" rating on the stock in a research note on Wednesday, July 16th. Piper Sandler cut their price target on shares of UnitedHealth Group from $552.00 to $353.00 and set an "overweight" rating for the company in a report on Tuesday, June 3rd. Finally, Wolfe Research cut their target price on UnitedHealth Group from $501.00 to $390.00 and set an "outperform" rating for the company in a research note on Tuesday, May 20th. One research analyst has rated the stock with a sell rating, nine have assigned a hold rating and fifteen have assigned a buy rating to the company's stock. According to MarketBeat, the stock has an average rating of "Moderate Buy" and an average target price of $394.43.

Insider Activity

In related news, Director Kristen Gil bought 3,700 shares of the company's stock in a transaction that occurred on Thursday, May 15th. The stock was purchased at an average price of $271.17 per share, for a total transaction of $1,003,329.00. Following the completion of the transaction, the director owned 3,818 shares in the company, valued at $1,035,327.06. The trade was a 3,135.59% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CEO Stephen J. Hemsley purchased 86,700 shares of the firm's stock in a transaction that occurred on Friday, May 16th. The shares were acquired at an average cost of $288.57 per share, for a total transaction of $25,019,019.00. Following the purchase, the chief executive officer owned 679,493 shares of the company's stock, valued at $196,081,295.01. This represents a 14.63% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have bought a total of 109,408 shares of company stock valued at $31,607,768 in the last three months. 0.28% of the stock is currently owned by insiders.

UnitedHealth Group Stock Performance

UnitedHealth Group stock traded down $13.99 during midday trading on Thursday, reaching $278.52. 22,499,738 shares of the company traded hands, compared to its average volume of 11,323,359. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.85 and a quick ratio of 0.85. UnitedHealth Group Incorporated has a 12 month low of $248.88 and a 12 month high of $630.73. The firm has a market capitalization of $252.66 billion, a price-to-earnings ratio of 11.66, a price-to-earnings-growth ratio of 1.39 and a beta of 0.45. The business has a 50 day moving average of $301.70 and a two-hundred day moving average of $428.82.

UnitedHealth Group Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, June 24th. Investors of record on Monday, June 16th were issued a $2.21 dividend. This is a boost from UnitedHealth Group's previous quarterly dividend of $2.10. This represents a $8.84 dividend on an annualized basis and a yield of 3.17%. The ex-dividend date was Monday, June 16th. UnitedHealth Group's dividend payout ratio (DPR) is currently 37.02%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.